UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
VTGN
VistaGen Therapeutics, Inc.
There isn't enough reported data to score VTGN yet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
VTGN Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Weak | |
| Unavailable |
VTGN's revenue is currently strong, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
VTGN PE Valuation
VTGN has no meaningful PE right now: it lost money over the past year.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
VTGN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect VTGN's losses to shrink, with revenue growing.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over VTGN on earnings quality, reporting a profit while its opponent remains loss making.
VTGN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.66 | +$0.13 |
| Q1 2026 | -$1.83 | -$0.16 |
| Q4 2023 | -$3.53 | +$5.77 |
| Q3 2023 | -$4.81 | +$4.49 |
| Q2 2023 | -$6.55 | +$2.45 |
| Q1 2023 | -$8.61 | -$1.41 |
| Q4 2022 | -$9.30 | +$1.50 |
| Q3 2022 | -$9.30 | +$2.10 |
VTGN is still losing money, but far less than before: $1.66 per share over the past year, against $20.70 at its worst in late 2019.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over VTGN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over VTGN on profitability, with a higher operating margin.
VTGN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.5M | +505% |
| Q4 2025 | $303K | +29% |
| Q3 2025 | $258K | +41% |
| Q2 2025 | $244K | +190% |
| Q4 2024 | $234K | -43% |
| Q3 2024 | $183K | -34% |
| Q1 2024 | $197.3K | +12% |
| Q1 2023 | $176K | +351% |
VTGN's revenue has grown year over year for five quarters in a row: $1M last quarter, up 505% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -904% | +5573 points |
| Q1 2026 | -3595% | N/A |
| Q4 2025 | -6451% | +11 points |
| Q3 2025 | -7772% | +1.8 points |
| Q2 2025 | -6477% | +7965 points |
| Q4 2024 | -6462% | -4545 points |
| Q3 2024 | -7774% | -5333 points |
| Q2 2024 | -14442% | N/A |
VTGN's operating margin was −904% last quarter, up 5573 points from the same quarter a year ago, near the top of its range since 2020.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over VTGN on cash generation, producing positive trailing cash flow while its opponent burns cash.
VTGN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$14.7M | +$4.1M |
| Q1 2026 | -$16.2M | -$6.1M |
| Q4 2025 | -$17.6M | -$7.4M |
| Q3 2025 | -$13.8M | -$2.9M |
| Q2 2025 | -$18.8M | -$8M |
| Q4 2024 | -$10.3M | -$5.7M |
| Q3 2024 | -$10.9M | -$4.7M |
| Q2 2024 | -$10.9M | -$3M |
VTGN has burned cash in almost every quarter: −$62M over the past year, against −$50M the year before.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over VTGN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
VTGN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +13% | +4.9M shares |
| 1 year | +35% | +11M shares |
| 3 years | +500% | +35.8M shares |
| 5 years | +783% | +38.1M shares |
| Available history | +2925% | +41.6M shares |
VTGN has 43M diluted shares, up 35% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
VTGN Net Leverage
VTGN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
VTGN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 1.6 | Oversold |
VTGN's weekly RSI is 31 (neutral) and its Stochastic is 2 (oversold).
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
VTGN PE vs Healthcare Sector
VTGN has no meaningful PE right now: it lost money over the past year.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over VTGN on trend strength, trading above more of its moving averages.
VTGN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.21 | 14% below |
| 20 week MA | $0.23 | 22% below |
| 50 week MA | $0.61 | 70% below |
| 100 week MA | $1.79 | 90% below |
| 200 week MA | $2.90 | 94% below |
VTGN is in a downtrend: it's below all five of its weekly moving averages, and 94% below its 200-week average.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over VTGN on returns for 2026, with the stronger performance.
VTGN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.0 | $41.7 | +99% |
| 2021 | $41.7 | $60.9 | +46% |
| 2022 | $60.9 | $3.00 | -95% |
| 2023 | $3.00 | $5.14 | +71% |
| 2024 | $5.14 | $2.57 | -50% |
| 2025 | $2.57 | $0.73 | -72% |
| 2026 YTD | $0.73 | $0.18 | -75% |
VTGN has finished lower in three of the last six years. It's down 75% so far in 2026.